Automatic low-loss nano-drug preparation system

By designing an automated low-loss nanodrug preparation system, the problems of cumbersome operation of microfluidic equipment and waste of raw materials are solved, and efficient automation and low-cost production of nanodrug preparation are achieved.

CN222093130UActive Publication Date: 2024-12-03MICRO&NANO BIOLOGICS CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202420122805.2
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-01-17
Publication Date
2024-12-03
Estimated Expiration
2034-01-17

AI Technical Summary

Technical Problem

The existing microfluidic equipment has not yet been automated, resulting in cumbersome operation, wasted time, low production efficiency, and serious waste of raw materials, which has increased R&D and production costs, and low clinical or toxicological batch recovery rate.

Method used

An automated low-loss nanomedicine preparation system is designed, including mixing devices, collection devices, control devices and feeding devices. It adopts material delivery pumps, bubble sensors, delay stop modules and flow sensors to achieve automated control and efficient fluid management and reduce waste. liquid generation.

Benefits of technology

It realizes a high degree of automation of nano-drug preparation, reduces artificial operations, improves production efficiency, saves expensive raw materials, reduces production costs, and ensures the stability of the preparation process and the low amount of waste liquid.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222093130U_ABST
    Figure CN222093130U_ABST
Patent Text Reader

Abstract

The utility model discloses an automatic low-loss nano-drug preparation system. The nano-drug preparation system comprises a mixing device, a collecting device and at least two feeding devices, the feeding device comprises a material containing device, a liquid feeding pipe, a material conveying pump, a liquid feeding multi-way valve, a liquid inlet pipe and a backflow pipe, the material conveying pump is connected to the liquid feeding pipe, one end of the liquid feeding pipe is connected with the material containing device, and the other end of the liquid feeding pipe is connected with the liquid inlet pipe and the backflow pipe through the liquid feeding multi-way valve. The other end of the return pipe is connected with the material accommodating device, and the liquid inlet pipe is connected to the mixing device; the collecting device comprises a discharging pipe and a sample containing device, and the sample containing device is connected with a discharging port of the mixing device through the discharging pipe. The preparation process comprises the steps of automatic material pre-filling, material backflow, sample preparation, sample collection and the like. The system is highly automatic, can realize continuous production, is good in process stability, realizes high flow rate, and avoids material waste to the greatest extent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the field of nano medicine, in particular to a nano medicine preparation system. Background Art

[0002] Microfluidics is a scientific technology that precisely controls and manipulates microscale fluids, with the main feature of manipulating fluids in micro-nanoscale space. It uses pipes with a scale of tens to hundreds of micrometers or millimeters to process or manipulate fluids from microliters to milliliters in the pipes.

[0003] Currently, the microfluidic devices that can be used for industrialization in the market have not yet been automated. Due to the design defects of the structural system, the entire operation process requires manual operation and manual control of the time of each step many times, which not only wastes time, but also seriously affects production efficiency. Without special process design, a large amount of raw materials is wasted, which increases the R&D and production costs of enterprises, and the recovery rate of clinical or toxicology batches is extremely low.

[0004] Therefore, in view of the above-mentioned technical problems, it is necessary to provide a new technical solution. Utility Model Content

[0005] In order to solve the technical problems existing in the prior art, the utility model provides an automated low-loss nano-drug preparation system, and the specific technical solution is as follows:

[0006] The utility model provides an automated low-loss nano-drug preparation system, comprising a mixing device, a collecting device, a control device and at least two feeding devices;

[0007] The feeding device includes a material containing device, a liquid feeding pipe, a material conveying pump, a liquid feeding multi-way valve, a liquid inlet pipe and a reflux pipe, the material feeding pump is connected to the liquid feeding pipe, one end of the liquid feeding pipe is connected to the material containing device, the other end of the liquid feeding pipe is respectively connected to the liquid inlet pipe and the reflux pipe through the liquid feeding multi-way valve, the other end of the reflux pipe is connected to the material containing device, and the other end of the liquid inlet pipe is connected to the feeding port of the mixing device;

[0008] The collecting device comprises a discharge pipe and a sample holding device, wherein the sample holding device is connected to a discharge port of the mixing device through the discharge pipe; the mixing device is configured to prepare a raw material liquid into a nano drug stock solution; and the control device controls the operation of the entire system.

[0009] As a preferred solution of the automated low-loss microfluidic system described in the present application, it also includes a preparation device, which includes a preparation liquid containing device, a preparation liquid feeding pipe and a preparation liquid delivery pump, one end of the preparation liquid feeding pipe is connected to the preparation liquid containing device, the other end of the preparation liquid feeding pipe is connected to the discharge pipe, the preparation liquid delivery pump is connected to the preparation liquid feeding pipe, and the preparation liquid delivery pump can suck the preparation liquid in the preparation liquid containing device into the preparation liquid feeding pipe;

[0010] The discharge pipe includes a first discharge pipe and a second discharge pipe, one end of the first discharge pipe is connected to the discharge port of the mixing device, the other end of the first discharge pipe and the other end of the preparation liquid feeding pipe are both connected to one end of the second discharge pipe, and the other end of the second discharge pipe is connected to the sample holding device.

[0011] As a preferred solution of the automated low-loss microfluidic system described in the present application, a bubble sensor is provided on the feeding device, and the bubble sensor is provided on the liquid inlet pipe.

[0012] As a preferred solution of the automated low-loss microfluidic system described in the present application, a bubble sensor is provided on the feeding device; the bubble sensor is configured to detect the end time of material pre-filling and / or nanomedicine preparation and / or whether gas is mixed in the raw material liquid.

[0013] As a preferred solution of the automated low-loss microfluidic system described in the present application, the control device includes a control module and a delayed stop module, and the delayed stop module is configured to delay a stop instruction issued by the control module by a set time.

[0014] As a preferred solution of the automated low-loss microfluidic system described in the present application, an emptying pump is also provided;

[0015] The emptying pump is arranged on the discharge pipe, and the emptying pump can pump the raw material liquid into the material conveying pump.

[0016] As a preferred solution of the automated low-loss microfluidic system described in the present application, the collection device is also provided with a sampling component, the sampling component includes at least one sampling receiving container, and the sampling receiving container can collect the liquid in the liquid outlet tube.

[0017] As a preferred solution of the automated low-loss microfluidic system described in the present application, a drain valve is provided on the liquid delivery tube, and the drain valve is provided on the side of the material delivery pump away from the material containing device, the access end of the drain valve is connected to the material delivery pump, one lead-out end of the drain valve is connected to the liquid delivery tube, and the other lead-out end of the drain valve is connected to a suction tube.

[0018] As a preferred solution of the automated low-loss microfluidic system described in the present application, there are two feeding devices, including a first feeding device and a second feeding device. The first feeding device can deliver the first raw material liquid to the mixing device, and the second feeding device can deliver the second raw material liquid to the mixing device.

[0019] As a preferred solution of the automated low-loss microfluidic system described in the present application, a flow sensor is provided on the second discharge pipe.

[0020] As a preferred solution of the automated low-loss microfluidic system described in the present application, a preparation liquid flow meter is also provided on the preparation liquid feeding pipe.

[0021] Compared with the prior art, the technical solution described in this patent has at least one or more of the following beneficial effects:

[0022] The nano drug preparation system of the present application is highly automated, and the control device can automatically control the entire preparation process, including automatic pre-filling, exhaust, automatic reflux, automatic preparation of nano drugs and switching of waste liquid before and after, etc. The entire process is automated and does not require manual operation; it can achieve continuous production, good process stability, repeatable batches, and less waste liquid. For expensive raw material liquids, it greatly saves R&D and production costs. The nano drug preparation system is mainly used in the preparation of nano drugs, especially the preparation of mRNA or other RNA drugs.

[0023] The material delivery pump is used to deliver the raw liquid to achieve a high flow rate, which can reach 800ml / min or even higher. It is suitable for the industrial preparation of nano-drugs, especially the preparation of nano-drugs to encapsulate RNA and DNA nucleic acid drugs.

[0024] The system adopts material pre-charging and material reflux, and is equipped with a bubble sensor and a delayed stop module to avoid material waste to the greatest extent, with the waste liquid volume less than 20ml.

[0025] The nano drug preparation process of the present application adopts material pre-charging to assist in pumping the raw material liquid into the corresponding raw material delivery pump, thereby solving the problem that the raw material delivery pump cannot pump the raw material liquid when there is no liquid in it.

[0026] By using material reflux, on the one hand, we wait for the material delivery pump to stabilize in order to obtain a stable flow rate; on the other hand, we exhaust the air in the material delivery pump and the liquid delivery pipe, solving the problem of manual exhaust of the high-pressure plunger pump; at the same time, material reflux also avoids the waste of raw material liquid. In addition, the size of the inner diameter of the reflux pipe helps to adjust the system's pressure stabilization time.

[0027] An emptying pump is set up to reduce the back pressure in the microfluidic mixing card and the liquid inlet pipe by sucking the discharge pipe, and the raw material liquid is sucked into the corresponding material delivery pump, which solves the problem that the material delivery pump cannot pump the raw material liquid into the microfluidic mixing card due to the existence of back pressure. Also setting up a suction pipe is another way to pre-charge materials.

[0028] The prepared nano drug stock solution is diluted with a diluent, which can make the nano drug stock solution more stable. The diluent is delivered in advance before the nano drug stock solution, that is, the diluent is pre-filled into the sample collection tube in advance when the material is refluxed. On the one hand, it is convenient to dilute the nano drug stock solution prepared in the microfluidic mixing card in time. On the other hand, the preparation effect of the nano drug stock solution prepared by mixing different raw material liquids in the early stage is not good. In order to obtain a better sample stock solution, the nano drug stock solution with poor mixing preparation effect in the early stage is required to be collected as waste liquid into the waste liquid holding device. When the waste liquid flows into the waste liquid holding device through the first discharge pipe, the second discharge pipe and the waste liquid pipe, part of the waste liquid will enter the sample collection tube through the multi-way connector, that is, the sample collection tube located at the front end of the pinch valve. The waste liquid will cause pollution to the nano drug liquid collected later, so the preparation liquid is introduced in advance, so that the preparation liquid occupies the sample collection tube located at the front end of the pinch valve, and the waste liquid is prevented from entering the sample holding device.

[0029] The bubble sensor can detect whether the raw material liquid is introduced into the liquid inlet pipe or there is no raw material liquid in the liquid inlet pipe, so as to facilitate the corresponding process flow operation in real time. It can monitor the position of the raw material liquid delivery during material pre-filling, and monitor when the raw material liquid is used up during nano-drug preparation, and switch to the next operation in time to reduce waste and ensure the excellent quality of the prepared nano-drug stock solution or nano-drug liquid.

[0030] A delayed stop module is set up, and when the control device issues a stop command, it continues to delay for a certain time, so as to collect as much nano drug stock solution or nano drug liquid as possible, avoid waste of raw material liquid, minimize the generation of waste liquid, and reduce experimental or production costs. The bubble sensor and the delayed stop module work together to accurately monitor the stop time and collect the nano drug stock solution or nano drug liquid to the maximum extent to avoid waste.

[0031] A flow sensor is provided to detect in real time whether the flow of each pipeline of the preparation system of the utility model is abnormal.

[0032] Additional aspects and advantages of the present invention will be given in part in the following description, and in part will become apparent from the following description, or will be learned through the practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] In order to more clearly illustrate the technical solution of the present invention, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0034] Figure 1 is a schematic diagram of the structure of the automated low-loss nanomedicine preparation system described in the present application;

[0035] Figure 2 It is a schematic diagram of the process for preparing nanomedicines described in the present application;

[0036] Figure 3 is a schematic diagram of the three-dimensional structure of the microfluidic hybrid card described in the present application;

[0037] Figure 4 is a schematic diagram of the exploded structure of the microfluidic hybrid card described in the present application;

[0038] Figure 5 is a schematic diagram of the three-dimensional structure of the microfluidic card described in this application;

[0039] Figure 6 A performance comparison chart of the particle size, PDI and waste liquid volume of nanodrugs prepared by the nanodrug preparation system of the present application and other existing commercial brand nanodrug preparation systems under the same preparation conditions;

[0040] Figure 7 This is a diagram showing implementation examples of various samples of the nanomedicine preparation system of this application;

[0041] Figure 8 This is an implementation example diagram of multiple preparations of the nano drug preparation system of this application;

[0042] Fig. 9 It is a structural schematic diagram of another embodiment of the automated low-loss nanomedicine preparation system described in the present application.

[0043] Among them, 1-microfluidic mixing card, 2-feeding device, 3-preparation device, 4-collection device, 11-feed port, 12-microchannel, 121-liquid inlet microchannel, 122-mixing microchannel, 13-discharge port, 14-microfluidic card, 15-shell, 201-first feeding device, 202-second feeding device, 21-material holding device, 22-liquid feeding pipe, 23-material delivery pump, 24-liquid feeding multi-way valve, 25-liquid inlet pipe, 26-reflux pipe , 27-bubble sensor, 28-drain valve, 29-suction tube, 31-prepared liquid containing device, 32-prepared liquid feeding tube, 33-prepared liquid delivery pump, 34-prepared liquid flow meter, 41-discharge pipe, 411-first discharge pipe, 412-second discharge pipe, 413-discharge valve, 42-sample containing device, 43-drain pump, 44-sample collecting tube, 45-drain pipe, 46-waste liquid pipe, 47-waste liquid containing device, 48-flow sensor. DETAILED DESCRIPTION

[0044] The embodiments of the utility model are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the utility model, and should not be construed as limitations on the utility model. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the utility model.

[0045] In the description of the present utility model, it is necessary to understand that the terms "upper", "lower", "top", "bottom", "inside", "outside", "front end", "rear end", "two ends", "one end", "the other end" and the like indicate positions or positional relationships based on the positions or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present utility model and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present utility model. In the description of the present utility model, the meaning of "multiple" is two or more, unless otherwise clearly and specifically defined. In addition, the terms "first" and "second" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance.

[0046] In the description of the present utility model, unless otherwise clearly specified and limited, the terms "provided with", "equipped with", "connected", "installed with", "set", "opened", "fixed" and the like should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral one; it can be a mechanical connection or an electrical connection; it can be directly connected or indirectly connected through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. For ordinary technicians in this field, the specific meanings of the above terms in the present utility model can be understood according to specific circumstances.

[0047] Additional aspects and advantages of the present invention will be given in part in the following description, and in part will become apparent from the following description, or will be learned through the practice of the present invention.

[0048] Example 1

[0049] According to one aspect of the present invention, the present invention discloses an automated low-loss nano-drug preparation system, see Figure 1 ,like Figure 1 As shown, it includes a mixing device, a collecting device, a control device and at least two feeding devices 2;

[0050] The feeding device 2 includes a material containing device 21, a liquid feeding pipe 22, a material conveying pump 23, a liquid feeding multi-way valve 24, a liquid inlet pipe 25 and a return pipe 26. The material conveying pump 23 is connected to the liquid feeding pipe 22. One end of the liquid feeding pipe 22 is connected to the material containing device 21. The other end of the liquid feeding pipe 22 is connected to the liquid inlet pipe 25 and the return pipe 26 through the liquid feeding multi-way valve 24. The other end of the return pipe 26 is connected to the material containing device 21. The other end of the liquid inlet pipe 25 is connected to the feed port of the mixing device.

[0051] The collecting device 4 includes a discharge pipe 41 and a sample holding device 42. The sample holding device 42 is connected to the discharge port of the mixing device through the discharge pipe 41. The prepared sample concentrate enters the discharge pipe 41 from the discharge port of the mixing device and is transported to the sample holding device 42 through the discharge pipe 41.

[0052] The control device controls the operation of the entire nanomedicine preparation system.

[0053] In the example, the raw material liquid is contained in the material containing device 21, the amount of the raw material liquid corresponds to the amount of the feeding device, one raw material liquid is transported to the mixing device through a feeding device, the mixing device is provided with a microfluidic channel, a discharge port and a plurality of feed ports, one raw material liquid corresponds to one feed port, different raw material liquids enter the microfluidic channel from the corresponding feed ports respectively, and then different raw material liquids are mixed in the microfluidic channel to prepare the nano drug stock solution. Preferably, the material containing device includes but is not limited to a raw material bottle, a disposable sterile connector or a disposable liquid storage bag, and the material delivery pump is preferably a high-pressure plunger pump. The mixing device is preferably a microfluidic mixing card 1.

[0054] Preferably, a discharge valve 413 is provided on the discharge pipe 41 , and the discharge valve 413 can control the flow of liquid in the discharge pipe 41 .

[0055] According to another aspect of the present invention, the present invention also discloses a process for preparing nanomedicine, which specifically comprises the following steps:

[0056] S1. Material pre-charging: There are at least two kinds of raw material liquids, which are respectively contained in corresponding material containing devices 21. The material delivery pump is connected to the liquid delivery pipe. The control device starts the material delivery pump, and the pumping device pumps the raw material liquids in the material containing devices into the corresponding material delivery pumps;

[0057] S2, material reflux: the control device controls the liquid delivery multi-way valve to connect the liquid delivery pipe with the reflux pipe, that is, the liquid delivery multi-way valve is adjusted to the reflux position, and the material delivery pump pumps the corresponding raw material liquid from the material holding device 21 to the material delivery pipe, and the raw material liquid flows from the material delivery pipe into the reflux pipe and finally flows back into the material holding device to perform material reflux;

[0058] S3, sample preparation: after the reflux is completed, the control device controls the liquid delivery multi-way valve to switch to connect the liquid delivery pipe with the liquid inlet pipe, that is, the liquid delivery multi-way valve is switched to the operation position, and the material delivery pump continues to pump the raw material liquid so that it passes through the liquid delivery pipe, the liquid delivery multi-way valve and the liquid inlet pipe in sequence and then flows into the mixing device, and different raw material liquids are mixed in the microchannel of the mixing device to prepare the nano drug stock solution;

[0059] S4: Sample collection: The prepared nano drug stock solution is transported from the discharge port of the mixing device through the discharge pipe to the sample holding device.

[0060] Among them, the reflux position means that the liquid delivery pipe is connected to the reflux pipe, and the operating position means that the liquid delivery pipe is connected to the liquid inlet pipe.

[0061] Preferably, in step S1, the control device starts the emptying pump, and the emptying pump pumps the raw material liquid into the corresponding material delivery pump, or the raw material liquid is manually pumped into the corresponding material delivery pump through a suction pipe.

[0062] In the example, in step S1, the raw material liquid can be one or more types, and different raw material liquids are matched with corresponding feeding devices.

[0063] Preferably, in step S2, the material reflux time can be freely set. Generally, the material reflux time is preferably 5-30s when preparing nanomedicines. Of course, other reflux times may be set according to actual conditions.

[0064] Preferably, the nano drug stock solution prepared by mixing different raw material liquids in the early stage has a poor preparation effect. In order to collect the nano drug stock solution with a better effect, the nano drug stock solution with a poor effect in the early stage is collected into the waste liquid holding device;

[0065] Preferably, in step S1, the pumping device is an emptying pump, the control device starts the emptying pump, and the emptying pump pumps the raw material liquid into the material conveying pump on the corresponding feeding pipe.

[0066] For step S1, the ratios of different raw material liquids are different, and the flow rates or inlet diameters of the raw material liquids are different. A raw material liquid with a fast flow rate reaches the mixing device first, and other raw material liquids with slow flow rates reach the mixing device later. Even if the ratios of different raw material liquids are the same, it is difficult to ensure that the different raw material liquids arrive at the mixing device at the same time. The raw material liquid that arrives at the mixing device later, before reaching the mixing device, forms a back pressure in the inlet pipe, causing the raw material liquid with a slow flow rate to be unable to continue to be transported under the resistance of the back pressure, so an external force is required to assist in pumping the raw material liquid into the corresponding raw material delivery pump.

[0067] For the material reflux of step S2, since the material delivery pump is unstable when it is just started, the flow rate of the raw material liquid is unstable, affecting the preparation ratio and preparation effect of the nano drug, and the residual air inside the liquid delivery pipe or pump head is also sucked into the material delivery pump, causing bubbles to be mixed in the raw material liquid delivered to the mixing device, and the bubbles will seriously affect the preparation effect of the nano drug, such as causing unstable flow rate, affecting the proportion of the raw material liquid and hindering the mixed preparation of different raw materials, etc., so it is necessary to reflux the raw material liquid, on the one hand, wait for the material delivery pump to be stable to obtain a stable flow rate; on the other hand, empty the residual air in the material delivery pump and the liquid delivery pipe, solve the problem that the high-pressure plunger pump needs to be manually exhausted; at the same time, the material reflux also avoids the waste of raw material liquid. Therefore, after the material pre-filling is completed, the control device switches the liquid delivery multi-way valve to the reflux position, and the material delivery pump refluxes the raw material liquid to the material holding device through the liquid delivery pipe and the reflux pipe in turn. The size of the inner diameter of the reflux pipe and the liquid inlet pipe helps to stabilize the fluid when switching from the material reflux to the sample preparation step, avoiding large fluctuations in the fluid and affecting the flow rate. Preferably, the back pressure of the return pipe is consistent with the back pressure generated by the liquid inlet pipe.

[0068] In the example, there are two feeding devices, including a first feeding device 201 and a second feeding device 202. The first feeding device 201 can deliver the first raw material liquid to the microfluidic mixing card, and the second feeding device 202 can deliver the second raw material liquid to the microfluidic mixing card. Of course, the feeding devices of this patent are not limited to two, but can also be three or more, and any number can be configured according to actual needs, for example, a corresponding number of feeding devices can be configured according to the number of raw material liquids, or a corresponding number of feeding devices can be configured according to the needs of process settings. In the example, the first raw material liquid is lipid raw material liquid (LNP), and the second raw material liquid is mRNA. The lipid raw material liquid and mRNA are mixed in a ratio of 1:3, so the flow rate ratio of the first raw material liquid and the second raw material liquid is 1:3. mRNA is expensive on the market, and the price of 1 mg mRNA is about RMB 10,000-15,000. If material pre-charging is not set, due to the faster flow rate of mRNA, mRNA will enter the microfluidic mixing card first, and LNP cannot enter the microfluidic mixing card under the action of back pressure. The two raw material liquids cannot be mixed for preparation, resulting in mRNA waste. Even a few dozen milliliters of waste will result in at least tens of thousands of raw material cost losses. Therefore, it is necessary to set two process steps of material pre-charging and material reflux to avoid raw material waste to the greatest extent, reduce the R&D cost and manufacturing cost of university enterprises, and prepare the best performance coated mRNA nucleic acid drug.

[0069] The mixing device can prepare nano drug stock solution from one or more raw material liquids by controlling the concentration, flow rate and / or different microchannel shapes, structures or inner diameter designs of the raw material liquids.

[0070] The mixing device is preferably a microfluidic mixing card, and the microfluidic mixing card 1 includes a microfluidic channel 12, a discharge port 13 and at least two feed ports 11; the microfluidic channel includes a liquid inlet microfluidic channel 121 and a mixing microfluidic channel 122. There are two kinds of raw liquids in the example, so there are two feed ports, and there are two liquid inlet microfluidic channels. The feed ports correspond to the liquid inlet microfluidic channels one by one, and the feed ports are connected to the liquid inlet microfluidic channels. The other ends of the two liquid inlet microfluidic channels are connected to the mixing microfluidic channels. The mixing microfluidic channel 122 is a vortex flow type mixing microfluidic channel, which is a vortex flow type mixing microfluidic channel composed of multiple S-type microfluidic channel structures connected end to end in sequence. Along the flow direction of the raw liquid, two adjacent S-type microfluidic channel structures are smoothly connected or staggered. If two adjacent S-type microfluidic channel structures are staggered, they can be staggered inside the previous S-type microfluidic channel structure or outside the previous S-type microfluidic channel structure. In the example, the latter S-shaped microfluidic structure is misplaced inside the former S-shaped microfluidic structure. In the example, both the feed port and the discharge port are provided with internal threads, the inlet pipe is threadedly connected to the feed port, and the discharge pipe is threadedly connected to the discharge port. The internal threads are provided, which is convenient and firm to install and can withstand the impact of high flow rate.

[0071] The microfluidic hybrid card 1 includes a shell 15 and a microfluidic card 14 accommodated in the shell. The discharge port 13 and the feed port 11 are arranged on the shell 15. The microchannel 12 is arranged in the microfluidic card 14. The microchannel 12 is connected to the discharge port 13 and the feed port 11 respectively.

[0072] Example 2

[0073] In this embodiment, based on the first embodiment, a drain pump is used to pre-fill the raw material liquid into the corresponding raw material delivery pump during material pre-filling.

[0074] The collecting device is also provided with an emptying pump 43. One end of the discharge pipe 41 is connected to the discharge port of the microfluidic mixing card, and the other end of the discharge pipe 41 is respectively connected to the sample collection pipe 44, the emptying pipe 45 and the waste liquid pipe 46. The other end of the sample collection pipe 44 is connected to the sample holding device 42, and the other end of the emptying pipe 45 and the other end of the waste liquid pipe 46 are both connected to the waste liquid holding device 47. The sample collection pipe 44, the emptying pipe 45 and the waste liquid pipe 46 are respectively installed with a pinch valve, and the emptying pump 43 is arranged on the emptying pipe 45. The emptying pump is arranged to discharge the back pressure in the microfluidic mixing card and the liquid inlet pipe by sucking the discharge pipe, and pre-fill the raw material liquid into the corresponding material delivery pump, which solves the problem that the material delivery pump cannot directly pump the raw material liquid into the microfluidic mixing card.

[0075] Preferably, the emptying pump 43 is a peristaltic pump, and the emptying pump 43 is arranged on the side of the clamping valve on the emptying pipe 45 away from the discharge pipe. The advantage of using a peristaltic pump for the emptying pump is that the peristaltic pump is installed on the emptying pipe, and the peristaltic pump does not contact the liquid in the emptying pipe. In the example, the other end of the discharge pipe 41 is respectively connected to the sample collection tube, the emptying pipe 45 and the waste liquid pipe 46 through a multi-way connector. Preferably, the multi-way connector is a sterile plastic multi-way connector. Of course, it is not limited to a multi-way connector, and can also be connected through a multi-way valve, etc., as long as a sterile connection of one-way and multiple pipelines can be achieved.

[0076] The specific steps of using the emptying pump to pump the raw material liquid into the corresponding raw material delivery pump include:

[0077] 1. The control device controls to close the pinch valves on the sample collection tube 44 and the waste liquid tube 46 respectively, and switches the switch of the liquid delivery multi-way valve 24 to the liquid delivery tube position;

[0078] 2. The control device starts the material delivery pump 23 and the drain pump 43 at the same time. The drain pump 43 pumps the raw material liquid in the material holding device 21 to the material delivery pump 23 through the discharge pipe 41, the microfluidic mixing card 1, the liquid inlet pipe 25 and the liquid delivery pipe 22.

[0079] 3. The emptying pump 43 sucks for a certain period of time, and the extraction time is automatically controlled by the sensor 27. The raw material liquid is transported to the material delivery pump 23, and the control device switches the switch of the liquid delivery multi-way valve 24 to the reflux pipe position. After that, the raw material liquid is no longer transported in the liquid inlet pipe 25. The emptying pump 43 continues to suck the raw material liquid that has entered the liquid inlet pipe 25, and pumps the raw material liquid that has entered the liquid inlet pipe 25 to the waste liquid holding device 47 through the emptying pipe 45.

[0080] Example 3

[0081] The nano drug preparation system provided in this embodiment is based on the embodiment 1 or embodiment 2, and the nano drug preparation system also includes a preparation device 3, the preparation device includes a preparation liquid containing device 31, a preparation liquid feeding pipe 32 and a preparation liquid delivery pump 33, one end of the preparation liquid feeding pipe 32 is connected to the preparation liquid containing device 31, the other end of the preparation liquid feeding pipe 32 is connected to the discharge pipe 41, and the preparation liquid delivery pump 33 is connected to the preparation liquid feeding pipe 32, and the preparation liquid delivery pump 33 can suck the preparation liquid in the preparation liquid containing device 31 into the preparation liquid feeding pipe 32. Preferably, the preparation liquid is a diluent, a modified solvent or a secondary reaction liquid. In the example, the preparation liquid is a diluent, and the diluent is added to the nano drug stock solution to prepare a nano drug liquid that needs to be diluted to a certain concentration. The effect of the diluent can make the nano drug stock solution more stable.

[0082] Preferably, the discharge pipe 41 includes a first discharge pipe 411 and a second discharge pipe 412, one end of the first discharge pipe 411 is connected to the discharge port of the microfluidic mixing card, the other end of the first discharge pipe 411 and the other end of the preparation liquid feeding pipe 32 are both connected to one end of the second discharge pipe 412, and the other end of the second discharge pipe 412 is respectively connected to the sample collection pipe 44, the emptying pipe 45 and the waste liquid pipe 46. In the example, the first discharge pipe 411, the second discharge pipe 412 and the preparation liquid feeding pipe 32 are connected by a multi-way pipe. Preferably, the multi-way pipe is a sterile plastic multi-way pipe.

[0083] Preferably, a pinch valve is provided on the preparation liquid feeding pipe 32, and the pinch valve can clamp the preparation liquid feeding pipe 32 to block the flow of liquid. In the example, the pinch valve is provided on a side of the preparation liquid delivery pump 33 away from the preparation liquid containing device 31.

[0084] In a preferred example, a flow sensor 48 is provided on the second discharge pipe 412, and the flow sensor 48 can monitor whether the flow in all pipelines is normal. If the flow in any pipeline such as the first feeding device, the second feeding device, the preparation device, etc. is abnormal, it will affect the value of the flow sensor. Therefore, by monitoring the flow sensor, it is possible to monitor whether the flow in the preparation system of this patent is normal.

[0085] The nano drug stock solution and the preparation solution are prepared to obtain the nano drug liquid, and the specific steps are as follows:

[0086] 1. Material pre-filling: There are at least two kinds of raw material liquids, which are respectively contained in the material containing devices 21 of the corresponding feeding devices. The control device controls to close the pinch valves on the sample collection tube 44 and the waste liquid tube 46 and the pinch valve on the dilution device respectively, and the control device starts the material delivery pumps 23 on the two feeding devices. At the same time, the control device activates the emptying pump or manually uses the suction pipe to pump at least two kinds of raw material liquids into the corresponding material delivery pumps to pre-fill the material delivery pumps;

[0087] 2. Material reflux: The control device controls the material delivery pump to start, and controls the liquid delivery multi-way valve to switch to the reflux position. The material delivery pump pumps the corresponding raw material liquid back to the material holding device through the reflux pipe to perform material reflux;

[0088] 3. Sample preparation: After the reflux is completed, the control device switches the liquid delivery multi-way valve to the running position, and the material delivery pump delivers the raw material liquid to the microfluidic mixing card through the liquid inlet pipe. Different raw material liquids are mixed in the microchannel of the microfluidic mixing card to prepare the nano drug stock solution;

[0089] 4. The control device starts the preparation liquid delivery pump 33, and the preparation liquid delivery pump 33 pumps the preparation liquid in the preparation liquid holding device 31 into the preparation liquid feeding pipe 32. The nano drug stock solution flows from the discharge port of the microfluidic mixing card to the first discharge pipe, and then the nano drug stock solution in the first discharge pipe and the preparation liquid in the preparation liquid feeding pipe 32 enter the second discharge pipe at their respective flow rates, and are mixed in the second discharge pipe to prepare nano drug liquid. The control device opens the clamping valve on the sample collection tube, and at the same time closes the clamping valve on the drain tube and the clamping valve on the waste liquid tube. The nano drug liquid is collected into the sample holding device through the sample collection tube.

[0090] Preferably, in order to collect nano drug liquid with better effect or ensure the good preparation effect of nano drug liquid, a small amount of nano drug liquid in the early stage will be discharged into the waste liquid holding device first. The specific operation is as follows: the control device first opens the clamp valve on the waste liquid pipe, and the early nano drug liquid is transported to the waste liquid holding device, and then the control device closes the clamp valve on the waste liquid pipe, and opens the clamp valve on the sample collection tube at the same time, and the prepared nano drug liquid is collected in the collection holding device. In a preferred embodiment, when the prepared nano drug liquid is transported to the sample holding device, the preparation liquid will be pre-filled in the discharge pipe in advance; specifically, before the material reflux ends, the preparation liquid delivery pump, the clamp valve on the preparation liquid feeding pipe and the clamp valve on the sample collection tube are opened to pre-fill the sample collection tube with the preparation liquid in advance. After the pre-filling is completed, the clamp valve on the sample collection tube is closed, and the sample collection tube located at the front end of the clamp valve is filled with the preparation liquid. On the one hand, the preparation liquid is transported in advance, which is convenient for timely dilution of the nano drug stock solution prepared in the microfluidic mixing card. On the other hand, the effect of the nano drug stock solution prepared by mixing different raw material liquids in advance cannot be guaranteed. In order to obtain a better nano drug stock solution, a small amount of the nano drug stock solution in the early stage needs to be discharged into the waste liquid holding device as waste liquid. When the waste liquid flows into the waste liquid holding device through the first discharge pipe, the second discharge pipe and the waste liquid pipe, part of the waste liquid will pass through the multi-way connector and enter the sample collection tube near the discharge pipe, that is, the sample collection tube at the front end of the clamp valve. The waste liquid will cause contamination to the nano drug liquid collected later. Therefore, the preparation liquid is introduced in advance to allow the preparation liquid to occupy the sample collection tube at the front end of the clamp valve to prevent the waste liquid from entering the sample collection tube. In the example, the preparation liquid is a diluent, and the flow rate of the diluent is 2-10 times the sum of the flow rates of the first raw material liquid and the second raw material liquid.

[0091] Example 4

[0092] The nano drug preparation system provided in this embodiment is based on any one or more of the above embodiments, and a bubble sensor 27 is provided on the liquid inlet pipe 25 .

[0093] The bubble sensor 27 can detect whether the liquid inlet pipe 25 located at the position of the bubble sensor 27 is full of liquid or whether the raw material liquid in the liquid inlet pipe is mixed with gas. The size of the detection value is negatively correlated with the amount of raw material liquid. The more gas there is in the liquid inlet pipe 25, the smaller the detection value is, and the more raw material liquid there is in the liquid inlet pipe 25, the larger the detection value is. The bubble sensor presets a threshold value. When the detection value is greater than the threshold value, it indicates that the liquid inlet pipe is full of raw material liquid. When the detection value is less than the threshold value, it indicates that gas has entered the liquid inlet pipe. The bubble sensor can detect whether there is raw material liquid in the liquid inlet pipe and whether there is gas mixed in the raw material liquid in the liquid inlet pipe, so as to facilitate the corresponding process flow operation in real time.

[0094] On the one hand, the bubble sensor can accurately control the end time of material pre-charging. The specific steps are as follows:

[0095] 1. The control device closes the pinch valve on the sample collection tube 44 and the pinch valve on the waste liquid tube 46 respectively, and switches the liquid feeding multi-way valve 24 to the liquid inlet tube position, and the control device starts the material delivery pump 23 and the emptying pump 43. Preferably, when the nano drug preparation system is installed with the preparation device as in Example 3, the control device closes the pinch valve on the sample collection tube 44 and the waste liquid tube 46 respectively, and also closes the pinch valve on the preparation liquid feeding tube 32;

[0096] 2. The emptying pump 43 pumps the raw material liquid in the material containing device 21 to pre-fill the material delivery pump 23 through the discharge pipe 41, the microfluidic mixing card 1, the liquid inlet pipe 25 and the liquid delivery pipe 22;

[0097] 3. The emptying pump 43 pumps the raw liquid to the position of the bubble sensor in the liquid inlet pipe 25. The detection value detected by the bubble sensor is greater than the threshold value. The bubble sensor sends a signal to the control device. After receiving the signal, the control device switches the liquid delivery multi-way valve to the reflux pipe position. After that, the raw liquid is no longer transported to the liquid inlet pipe 25, but flows back to the raw material containing device through the reflux pipe 26. The emptying pump 43 continues to suck the raw liquid that has entered the liquid inlet pipe 25, and collects the raw liquid that has entered the liquid inlet pipe 25 in the waste liquid containing device 47 through the emptying pipe 45.

[0098] The bubble sensor can monitor the position of the raw material liquid delivery in real time and accurately control the delivery amount of the raw material liquid during material pre-filling, which can greatly reduce the waste of raw material liquid. The bubble sensor is set on the liquid inlet pipe. When the bubble sensor detects the raw material liquid, it means that the raw material liquid has been pre-filled into the material delivery pump, and the control device can stop the material pre-filling action.

[0099] On the other hand, the bubble sensor can also monitor the end time of the preparation of nano-drug concentrate or nano-drug liquid. The specific principle and process are as follows: During the preparation of nano-drugs, the raw liquid continuously flows through the bubble sensor to be transported into the microfluidic mixing card. After the raw liquid is transported, no raw liquid flows through the bubble sensor. The bubble sensor detects a value less than the threshold value, and the bubble sensor sends a signal to the control device. After receiving the signal, the control device stops the system operation and completes the preparation of the nano-drug.

[0100] Because the flow rate or purity of the raw material liquid at the end may have an impact, the particle size, PDI, and structural drug performance effects of the prepared nano drug stock solution have large differences. Therefore, it is necessary to treat the nano drug stock solution or nano drug liquid prepared from the raw material liquid at the end as waste liquid to avoid the nano drug stock solution or nano drug liquid at the end affecting the overall performance indicators. The waste liquid at the end can flow naturally into the waste liquid holding device through the waste liquid pipe under the action of gravity, and can also be pumped into the waste liquid holding device through the emptying pipe using an emptying pump. Preferably, an emptying pump is used to pump the waste liquid at the end into the waste liquid holding device. When collecting the waste liquid at the end, the control device closes the clamp valve on the sample collection tube, and opens the clamp valve on the emptying tube at the same time, and then the control device starts the emptying pump, and the emptying pump pumps the waste liquid at the end into the waste liquid holding device. Therefore, setting up a bubble sensor plays an important role. It can automatically control the end time of nanomedicine preparation, without the need to manually monitor the preparation progress of nanomedicine, and manual monitoring is prone to errors, and it is not possible to well control the node where the collection of nanomedicines is stopped. The bubble sensor can well ensure the quality of the prepared nanomedicine stock solution or nanomedicine liquid. At the same time, it is also possible to determine whether there is gas mixed in the raw liquid by monitoring the detection value of the bubble sensor to ensure the quality of the prepared nanomedicine. That is, when the detection value of the bubble sensor is less than the threshold value, it means that there is gas mixed in the corresponding raw liquid or the corresponding raw liquid is used up, and the preparation of the nanomedicine stock solution or nanomedicine liquid is stopped.

[0101] Example 5

[0102] The nano drug preparation system provided in this embodiment is based on the embodiment 4, and the control device is provided with a delayed stop module. The control device includes a control module and a delayed stop module, and the delayed stop module can delay the stop instruction issued by the control module by a set time. Preferably, the set time that the delayed stop module can delay can be set to different times according to specific needs.

[0103] During the preparation of nano drug stock solution or nano drug liquid, if the bubble sensor detects that there is no raw material liquid in the liquid inlet pipe, the control device stops the operation of the nano drug preparation system after a delay of a set time. Preferably, the delay stop module can be set with different set times, and the user can set different set times according to the different viscosities of the raw material liquid, nano drug liquid or nano drug stock solution and the different lengths of the discharge pipe.

[0104] The specific operating principle is as follows: there are at least two kinds of raw material liquids. As long as one bubble sensor detects that there is no raw material liquid in the liquid inlet pipe, it means that the raw material liquid in the corresponding raw material containing device has been used up or the feeding device fails to convey the raw material liquid. Then the control module of the control device issues a stop command to control the entire nano drug preparation system to stop running and no longer continue to prepare nano drug stock or nano drug liquid. However, the raw material liquid that has flowed into the liquid inlet pipe and the microfluidic core box and the discharge pipe are still full of some nano drug liquid or nano drug stock with good performance. Therefore, it is necessary to continue to collect these nano drug stock or nano drug liquid with good performance that have been prepared or to be prepared into the sample containing device. Therefore, a delayed stop module is set. When the control device issues a stop command, it continues to delay the set time, so as to collect as much nano drug stock or nano drug liquid as possible, avoid the waste of raw material liquid, minimize the generation of waste liquid, and reduce the cost of experiment or production. The bubble sensor and the delayed stop module cooperate with each other, that is, they can accurately monitor the stop time, and at the same time, they can collect nano drug stock or nano drug liquid to the maximum extent to avoid waste.

[0105] Example 6

[0106] Based on any one or more of the above embodiments, a suction pipe is used to pump the raw material liquid into a corresponding raw material delivery pump.

[0107] A drain valve 28 is provided on the liquid delivery pipe 22. The drain valve 28 is provided on a side of the material delivery pump 23 away from the material containing device 21. The access end of the drain valve 28 is connected to the material delivery pump 23. One lead end of the drain valve 28 is connected to the liquid delivery pipe 22. The other lead end of the drain valve 28 is connected to a suction pipe 29. The suction pipe 29 can pump the raw material liquid into the material delivery pump. In the example, the drain valves on the two feeding devices are connected to the suction pipe 29 to realize the material pre-filling of the two raw material liquids. In the example, the suction pipe is a syringe. In the example, the drain valve 28 is provided with a pressure sensor, which can detect the pressure of the liquid pipeline after the material delivery pump 23 to detect whether the nano drug preparation system is running smoothly.

[0108] The liquid delivery pipe 22 includes a front liquid delivery pipe, a middle liquid delivery pipe and a rear liquid delivery pipe. The material holding device 21 and the material delivery pump 23 are connected through the front liquid delivery pipe, the material delivery pump 23 and the emptying valve 28 are connected through the middle liquid delivery pipe, and the emptying valve 28 and the liquid delivery multi-way valve 24 are connected through the rear liquid delivery pipe. An adjusting button is set on the emptying valve 28, and the adjusting button can switch the emptying valve 28 to the rear liquid delivery pipe position or the suction pipe position. When the adjusting button is switched to the suction pipe position, the suction pipe pumps the raw material liquid into the material delivery pump through the middle liquid delivery pipe and the front liquid delivery pipe. After the material pre-charging is completed, the adjusting button on the emptying valve 28 is switched to the liquid delivery pipe position to deliver the raw material liquid to the liquid inlet pipe 25 or the reflux pipe 26. A suction pipe is set to suck the raw material liquid into the material delivery pump to solve the problem that the raw material liquid cannot be pumped when there is no liquid inside the material delivery pump.

[0109] Example 7

[0110] The utility model also discloses another automated low-loss nano drug preparation system, please refer to Fig. 9 ,like Fig. 9 As shown, it includes a mixing device, a collecting device 4, a control device and at least two feeding devices 2;

[0111] The feeding device 2 includes a material containing device 21, a liquid feeding pipe 22, a material conveying pump 23, a liquid feeding multi-way valve 24, a liquid inlet pipe 25 and a return pipe 26. The material conveying pump 23 is connected to the liquid feeding pipe 22. One end of the liquid feeding pipe 22 is connected to the material containing device 21. The other end of the liquid feeding pipe 22 is connected to the liquid inlet pipe 25 and the return pipe 26 through the liquid feeding multi-way valve 24. The other end of the return pipe 26 is connected to the material containing device 21. The other end of the liquid inlet pipe 25 is connected to the feed port of the mixing device.

[0112] The collecting device 4 includes a discharge pipe 41 and a sample holding device 42. The sample holding device 42 is connected to the discharge port of the mixing device through the discharge pipe 41. The prepared sample stock solution enters the discharge pipe 41 from the discharge port of the mixing device and is transported to the sample holding device 42 through the discharge pipe 41.

[0113] The control device controls the operation of the entire nanomedicine preparation system.

[0114] In the example, the raw material liquid is contained in the material containing device 21, the amount of the raw material liquid corresponds to the amount of the feeding device, one raw material liquid is transported to the mixing device through a feeding device, the mixing device is provided with a microfluidic channel, a discharge port and a plurality of feed ports, one raw material liquid corresponds to one feed port, different raw material liquids enter the microfluidic channel from the corresponding feed ports respectively, and then different raw material liquids are mixed in the microfluidic channel to prepare the nano drug stock solution. Preferably, the material containing device includes but is not limited to a raw material bottle, a disposable sterile connector or a disposable liquid storage bag, and the material delivery pump is preferably a high-pressure plunger pump. The mixing device is preferably a microfluidic mixing card 1.

[0115] Preferably, a discharge valve 413 is provided on the discharge pipe 41 , and the discharge valve 413 can control the flow of liquid in the discharge pipe 41 .

[0116] Preferably, the liquid delivery pipe 22 is also provided with a liquid delivery flow meter, and the flow meter can detect the flow rate of the liquid delivered in the corresponding material containing device.

[0117] In a preferred embodiment, the collection device further includes a sampling assembly, which includes at least one parallel sampling storage container 401, which is connected to the discharge pipe through a liquid pipe, and a liquid valve 402 is also provided on the liquid pipe, which can control whether the liquid in the discharge pipe flows into the sampling storage container. Preferably, according to actual needs, multiple groups of sampling storage containers can be provided or installed on the sampling assembly to collect liquids prepared at different stages or different time periods, so as to facilitate monitoring of the liquid preparation process, quality stability, etc.

[0118] In the example, the sample holding device is disposed on the sampling assembly. The sample holding device is also provided with a corresponding liquid valve to control whether the sample holding device collects the nano drug stock solution or the nano drug liquid. Of course, the sample holding device can also be directly disposed on the liquid outlet pipe together with the corresponding liquid valve, and this patent does not limit this.

[0119] Preferably, the sampling assembly is also provided with a waste liquid holding device 47 for collecting waste liquid. Further preferably, the waste liquid holding device 47 is also provided with a liquid valve, which is configured to control whether to collect liquid or waste liquid into the waste liquid holding device 47.

[0120] In a preferred embodiment, a preparation device 3 is also included, the preparation device includes a preparation liquid holding device 31, a preparation liquid feeding pipe 32 and a preparation liquid delivery pump 33, one end of the preparation liquid feeding pipe 32 is connected to the preparation liquid holding device 31, the other end of the preparation liquid feeding pipe 32 is connected to the discharge pipe 41, and the preparation liquid delivery pump 33 is connected to the preparation liquid feeding pipe 32, and the preparation liquid delivery pump 33 can suck the preparation liquid in the preparation liquid holding device 31 into the preparation liquid feeding pipe 32. Preferably, the preparation liquid is a diluent, a modified solvent or a secondary reaction liquid, etc. Preferably, the preparation device can have one or more. Multiple preparation devices can prepare preparation liquids of different types or different concentrations to the nano drug liquid respectively, to obtain the required target liquid. Multiple preparation devices can also prepare the same preparation liquid of the same concentration, and obtain the target liquid by step-by-step preparation. In the example, there are two preparation devices, both of which contain the same diluent of the same concentration. The diluent is added to the nano drug stock solution to prepare the nano drug liquid that needs to be diluted to a certain concentration. The diluent can make the nano drug stock solution more stable. In the example, the two preparation devices 3 are set with different flow rates.

[0121] Preferably, the preparation liquid feeding pipe 32 is further provided with a preparation liquid valve 34, which can control the flow of liquid in the preparation liquid feeding pipe 32. Further preferably, the preparation liquid valve 34 is arranged on a side of the preparation liquid delivery pump 33 away from the preparation liquid containing device 31. Of course, the present patent is not limited to this.

[0122] Preferably, the preparation liquid feeding pipe 32 is also provided with a preparation liquid flow meter 35, which can detect the flow of the preparation liquid. Further preferably, the preparation liquid flow meter 35 is located between the preparation liquid valve 34 and the preparation liquid delivery pump 33. Of course, the present invention is not limited to this.

[0123] According to another aspect of the present invention, the present invention also discloses a process for preparing nanomedicine, which specifically comprises the following steps:

[0124] S1. Material pre-charging: There are at least two kinds of raw material liquids, which are respectively contained in corresponding material containing devices 21. The material delivery pump is connected to the liquid delivery pipe. The control device starts the material delivery pump to run, and the raw material liquids are respectively pumped into the corresponding material delivery pumps;

[0125] S2, material reflux: the control device controls the liquid delivery multi-way valve to connect the liquid delivery pipe with the reflux pipe, that is, the liquid delivery multi-way valve is adjusted to the reflux position, and the material delivery pump pumps the corresponding raw material liquid from the material holding device 21 to the material delivery pipe, and the raw material liquid flows from the material delivery pipe into the reflux pipe and finally flows back into the material holding device to perform material reflux;

[0126] S3, sample preparation: after the reflux is completed, the control device controls the liquid delivery multi-way valve to switch to connect the liquid delivery pipe with the liquid inlet pipe, that is, the liquid delivery multi-way valve is switched to the operation position, and the material delivery pump continues to pump the raw material liquid so that it passes through the liquid delivery pipe, the liquid delivery multi-way valve and the liquid inlet pipe in sequence and then flows into the mixing device, and different raw material liquids are mixed in the microchannel of the mixing device to prepare the nano drug stock solution;

[0127] S4: Sample collection: The prepared nano drug stock solution is transported from the discharge port of the mixing device through the discharge pipe to the sample holding device.

[0128] Among them, the reflux position means that the liquid delivery pipe is connected to the reflux pipe, and the operating position means that the liquid delivery pipe is connected to the liquid inlet pipe.

[0129] Preferably, in step S4, before sample collection, the control device starts the preparation liquid delivery pump 33, and the preparation liquid delivery pump 33 pumps the preparation liquid in the preparation liquid containing device 31 into the preparation liquid feeding tube 32, and the nano drug stock solution flows from the discharge port of the microfluidic mixing card to the discharge tube, and then the preparation liquid delivery pump 33 and the preparation liquid valve 34 are opened, and the preparation liquid enters the discharge tube through the preparation liquid feeding tube 32, and the preparation liquid is mixed with the nano drug stock solution to prepare a nano drug liquid, and the control device opens the collection valve corresponding to the sample receiving device 42, and the nano drug liquid is collected into the sample containing device through the sample collection tube.

[0130] Preferably, in order to collect nano drug liquid with better effect or ensure the good preparation effect of nano drug liquid, a small amount of nano drug liquid in the early stage will be discharged into the waste liquid holding device first. The specific operation is as follows: the control device first opens the clamp valve on the waste liquid pipe to transport the early nano drug liquid to the waste liquid holding device, and then the control device closes the clamp valve on the waste liquid pipe, and opens the clamp valve on the sample collection tube at the same time, and the prepared nano drug liquid is collected in the collection holding device. In a preferred embodiment, when the prepared nano drug liquid is transported to the sample holding device, the preparation liquid will be pre-filled in the discharge pipe in advance; specifically, before the material reflux ends, the preparation liquid delivery pump, the clamp valve on the preparation liquid feeding pipe and the clamp valve on the sample collection tube are opened to pre-fill the sample collection tube with the preparation liquid in advance. After the pre-filling is completed, the clamp valve on the sample collection tube is closed, and the sample collection tube located at the front end of the clamp valve is filled with the preparation liquid.

[0131] In the example, in step S1, the raw material liquid can be one or more types, and different raw material liquids are matched with corresponding feeding devices.

[0132] Preferably, in step S2, the material reflux time can be freely set. Generally, the material reflux time is preferably 5-30s when preparing nanomedicines. Of course, other reflux times may be set according to actual conditions.

[0133] Preferably, the nano drug stock solution prepared by mixing different raw material liquids in the early stage has a poor preparation effect. In order to collect nano drug stock solutions with better effects, the nano drug stock solutions with poor effects in the early stage are collected in a waste liquid holding device.

[0134] Preferably, in step S1, the control device starts the emptying pump, and the emptying pump pumps the raw material liquid into the material delivery pump on the corresponding feeding pipe, so that the material delivery pump pumps the raw material liquid.

[0135] For step S1, the ratios of different raw material liquids are different, and the flow rates or inlet diameters of the raw material liquids are different. A raw material liquid with a fast flow rate reaches the mixing device first, and other raw material liquids with slow flow rates reach the mixing device later. Even if the ratios of different raw material liquids are the same, it is difficult to ensure that the different raw material liquids arrive at the mixing device at the same time. The raw material liquid that arrives at the mixing device later, before reaching the mixing device, forms a back pressure in the inlet pipe, causing the raw material liquid with a slow flow rate to be unable to continue to be transported under the resistance of the back pressure, so an external force is required to assist in pumping the raw material liquid into the corresponding raw material delivery pump.

[0136] For the material reflux of step S2, since the material delivery pump is unstable when it is just started, the flow rate of the raw material liquid is unstable, affecting the preparation ratio and preparation effect of the nano drug, and the residual air inside the liquid delivery pipe or pump head is also sucked into the material delivery pump, causing bubbles to be mixed in the raw material liquid delivered to the mixing device, and the bubbles will seriously affect the preparation effect of the nano drug, such as causing unstable flow rate, affecting the proportion of the raw material liquid and hindering the mixed preparation of different raw materials, etc., so it is necessary to reflux the raw material liquid, on the one hand, wait for the material delivery pump to be stable to obtain a stable flow rate; on the other hand, empty the residual air in the material delivery pump and the liquid delivery pipe, solve the problem that the high-pressure plunger pump needs to be manually exhausted; at the same time, the material reflux also avoids the waste of raw material liquid. Therefore, after the material pre-filling is completed, the control device switches the liquid delivery multi-way valve to the reflux position, and the material delivery pump refluxes the raw material liquid to the material holding device through the liquid delivery pipe and the reflux pipe in turn. The size of the inner diameter of the reflux pipe and the liquid inlet pipe helps to stabilize the fluid when switching from the material reflux to the sample preparation step, avoiding large fluctuations in the fluid and affecting the flow rate. Preferably, the back pressure of the return pipe is consistent with the back pressure generated by the liquid inlet pipe.

[0137] In the example, there are two feeding devices, including a first feeding device 201 and a second feeding device 202. The first feeding device 201 can deliver the first raw material liquid to the microfluidic mixing card, and the second feeding device 202 can deliver the second raw material liquid to the microfluidic mixing card. Of course, the feeding devices of this patent are not limited to two, but can also be three or more, and any number can be configured according to actual needs, for example, a corresponding number of feeding devices can be configured according to the number of raw material liquids, or a corresponding number of feeding devices can be configured according to the needs of process settings.

[0138] The mixing device can prepare nano drug stock solution by controlling the concentration, flow rate and / or different microchannel shapes, structures or inner diameter designs of one or more raw material liquids. The mixing device is preferably a microfluidic mixing card, which is the same as that in Example 1. Of course, this patent is not limited thereto, and can also be a microfluidic mixing card with other structures.

[0139] In a preferred embodiment, a flow meter is installed on the liquid delivery pipe, and the flow meter can detect the flow rate of the liquid in the liquid delivery pipe.

[0140] In a preferred embodiment, the collecting device is further provided with an emptying pump 43, which can pump the raw material liquid into the material delivery pump on the corresponding feeding pipe. Fig. 9 As shown, the drain pump 43 is also connected to a waste liquid holding device 47 to collect the pumped waste liquid into the waste liquid holding device 47. Further preferably, a switch valve 431 is further provided on the side of the drain pump 43 away from the waste liquid holding device 47, and the switch valve 431 can be controlled.

[0141] In a preferred embodiment, a bubble sensor 27 is provided on the liquid inlet pipe 25, and the bubble sensor 27 can detect whether the liquid inlet pipe 25 is full of liquid or whether there is gas mixed in the raw material liquid in the liquid inlet pipe.

[0142] In a preferred embodiment, a delay control module is further included, and the delay control module facilitates sufficient collection of the prepared nano drug stock solution or nano drug liquid.

[0143] Example 8

[0144] The nano drug liquid prepared in Example 3 was compared with the nano drug preparation systems of other brands with the same specifications. Figure 6 As shown, the amount of waste liquid produced by the nano-drug preparation system of this patent is less than 12 mL, which is significantly lower than that of other brands of preparation systems. The amount of waste liquid produced by other existing commercial brands of preparation systems when preparing nano-drugs is about 100 mL, which causes great waste of raw liquid and seriously increases the cost of R&D investment. In addition, under the condition of equivalent preparation prescription and preparation conditions, the PDI dispersibility of the prepared nano-drug is 0.05, which has good dispersibility, and the average particle size of the nano-drug is 50 nm. Under the same conditions, the dispersibility of the prepared nano-drugs of other existing commercial brands of preparation systems is very poor, which are 0.15 and 0.17 respectively, and the average particle size of the nano-drugs is also larger, which are 58 nm and 60 nm respectively.

[0145] The nano drug preparation system of the utility model can well realize the conversion from low flow rate to high flow rate, such as Figure 7 and Figure 8 As shown in the figure, the small and medium-sized equipment is the patent equipment previously applied for by the applicant (patent number: 2021227729256). The small equipment is mainly used for the preparation of low-flow nano-drugs developed in the laboratory. The nano-drug preparation system of the utility model is a high-flow automated preparation system of the same series. Figure 7 It can be seen that for the same sample, the physical and chemical data of the sample prepared by the small-scale equipment and the preparation system of the utility model are basically consistent, such as the average particle size of the sample, PDI dispersity, etc. In addition, the PDI dispersity is kept below 0.1, and the recovery rate is high. Figure 8 In the present invention, the raw material liquid of a nano drug (referred to as sample) includes LNP and mRNA, the flow rate ratio of LNP and mRNA is 1:3, the total flow rate of LNP and mRNA is 80-100ml / min, the preparation liquid is the diluent, the flow rate of the diluent is 200-400ml / min, the LNP and mRNA reflux time is 30s, and the unstable quality sample is sucked into the waste liquid bottle as waste liquid in the early stage of sample preparation, and the waste liquid suction time is 10s. Figure 8 It can be seen that the physical and chemical data of the same sample prepared three times using the preparation system of this patent are basically consistent, and are also basically consistent with the physical and chemical data of the sample prepared by small-scale equipment, indicating that the preparation system of this patent is repeatable, has good repeatability, stable preparation, and good preparation effect.

[0146] The above embodiments or component structures can be freely combined without conflict. In addition, changes, modifications and variations in component structures and process flows are also within the protection scope of this patent.

[0147] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "yet another embodiment", "another embodiment", "other embodiments", "example", "specific example" or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the utility model. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification.

[0148] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify and vary the above embodiments within the scope of the present invention.

Claims

1. An automated low-loss nano-drug preparation system, characterized in that: It includes a mixing device, a collecting device, a control device and at least two feeding devices; The feeding device comprises a material containing device (21), a liquid feeding pipe (22), a material conveying pump (23), a liquid feeding multi-way valve (24), a liquid inlet pipe (25) and a return pipe (26); the material feeding pump (23) is connected to the liquid feeding pipe (22); one end of the liquid feeding pipe (22) is connected to the material containing device (21); the other end of the liquid feeding pipe (22) is respectively connected to the liquid inlet pipe (25) and the return pipe (26) via the liquid feeding multi-way valve (24); the other end of the return pipe (26) is connected to the material containing device (21); and the other end of the liquid inlet pipe (25) is connected to the feed port of the mixing device; The collecting device comprises a discharge pipe (41) and a sample holding device (42), wherein the sample holding device (42) is connected to a discharge port of the mixing device through the discharge pipe (41); the mixing device is configured to prepare a raw material liquid into a nano drug stock solution; The control device controls the operation of the entire system.

2. The automated low-loss nano-drug preparation system according to claim 1, characterized in that: The preparation device (3) further comprises a preparation liquid containing device (31), a preparation liquid feeding pipe (32) and a preparation liquid delivery pump (33), one end of the preparation liquid feeding pipe (32) is connected to the preparation liquid containing device (31), the other end of the preparation liquid feeding pipe (32) is connected to the discharge pipe (41), the preparation liquid delivery pump (33) is connected to the preparation liquid feeding pipe (32), and the preparation liquid delivery pump (33) can suck the preparation liquid in the preparation liquid containing device (31) into the preparation liquid feeding pipe (32); The discharge pipe (41) includes a first discharge pipe (411) and a second discharge pipe (412), one end of the first discharge pipe (411) is connected to the discharge port of the mixing device, the other end of the first discharge pipe (411) and the other end of the preparation liquid feeding pipe (32) are both connected to one end of the second discharge pipe (412), and the other end of the second discharge pipe (412) is connected to the sample holding device (42).

3. The automated low-loss nano-drug preparation system according to claim 1, characterized in that: The feeding device is provided with a bubble sensor, which is configured to detect the end time of material pre-charging and / or nano-drug preparation and / or whether gas is mixed in the raw material liquid.

4. The automated low-loss nano-drug preparation system according to claim 2, characterized in that: The control device includes a control module and a delay stop module, wherein the delay stop module is configured to delay a stop instruction issued by the control module by a set time.

5. The automated low-loss nano-drug preparation system according to any one of claims 1 to 3, characterized in that: An emptying pump (43) is also provided; The emptying pump (43) is arranged on the discharge pipe (41), and the emptying pump (43) can pump the raw material liquid into the material conveying pump (23).

6. The automated low-loss nano-drug preparation system according to any one of claims 1 to 3, characterized in that: The collecting device is also provided with a sampling assembly, which includes at least one sampling storage container (401), and the sampling storage container (401) is capable of collecting liquid in the liquid outlet tube.

7. The automated low-loss nano-drug preparation system according to claim 1, characterized in that: There are two feeding devices (2), including a first feeding device (201) and a second feeding device (202). The first feeding device (201) can deliver the first raw material liquid to the mixing device, and the second feeding device (202) can deliver the second raw material liquid to the mixing device.

8. The automated low-loss nano-drug preparation system according to claim 2, characterized in that: A flow sensor (48) is provided on the second discharge pipe (412); and / or The preparation liquid feeding pipe (32) is also provided with a preparation liquid flow meter (35).

Citation Information

Cited By

  • Automatic low-loss nano-drug preparation process and system

    CN118162020A